AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares

18-Jul-2018 - Switzerland

AC Immune SA announced that it is commencing offerings of up to 10 million new common shares of the Company with a nominal value of CHF 0.02 each. The Company intends to issue all new common shares against cash contributions as approved by the Company's shareholders.

The Company plans to use the proceeds from the offerings primarily to fund research and development expenses for the Company's clinical and pre-clinical research and development activities, for working capital and the remainder for general corporate purposes.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances